BACKGROUND: The islet size distribution in a preparation may contribute to islet transplant outcomes. At the same islet equivalent (IE) dose, larger islets may exhibit poorer therapeutic value and this may be because of oxygen diffusion limitations that worsen in proportion to islet size. METHODS: To test this hypothesis, we studied the impact of islet size index (ISI) and other islet product characteristics on outcomes after islet autotransplant (IAT) in recipients receiving a marginal islet dose (2000-4999 IEs per kg body weight) from January 1, 2009 to June 11, 2012, at the University of Minnesota (n=58). ISI was defined as the number of IE divided by the number of islet particles (IPs) in a preparation; an ISI less than 1 indicates a mean islet diameter that is less than 150 μm. The primary post-IAT outcome was 6-month insulin use status. RESULTS: Logistic regression analysis indicate that IPs/kg (P=0.001), IEs/kg (P=0.019), total IPs transplanted (P=0.040), and ISI (P=0.074) were most strongly correlated with the primary outcome. The ISI (mean±standard error) was lower for recipients achieving insulin independence at 6 months (0.71±0.05) versus those partially (0.83±0.05) or completely (1.00±0.07) insulin dependent. The combination of islet dose (expressed as units IPs/kg) and ISI exhibited a sensitivity of 75% and specificity of 74% in predicting insulin independence in this population of patients. CONCLUSION: Islet autotransplant recipients of a marginal islet doses were more likely to achieve insulin independence when transplanted with a greater number of smaller islets.
BACKGROUND: The islet size distribution in a preparation may contribute to islet transplant outcomes. At the same islet equivalent (IE) dose, larger islets may exhibit poorer therapeutic value and this may be because of oxygen diffusion limitations that worsen in proportion to islet size. METHODS: To test this hypothesis, we studied the impact of islet size index (ISI) and other islet product characteristics on outcomes after islet autotransplant (IAT) in recipients receiving a marginal islet dose (2000-4999 IEs per kg body weight) from January 1, 2009 to June 11, 2012, at the University of Minnesota (n=58). ISI was defined as the number of IE divided by the number of islet particles (IPs) in a preparation; an ISI less than 1 indicates a mean islet diameter that is less than 150 μm. The primary post-IAT outcome was 6-month insulin use status. RESULTS: Logistic regression analysis indicate that IPs/kg (P=0.001), IEs/kg (P=0.019), total IPs transplanted (P=0.040), and ISI (P=0.074) were most strongly correlated with the primary outcome. The ISI (mean±standard error) was lower for recipients achieving insulin independence at 6 months (0.71±0.05) versus those partially (0.83±0.05) or completely (1.00±0.07) insulin dependent. The combination of islet dose (expressed as units IPs/kg) and ISI exhibited a sensitivity of 75% and specificity of 74% in predicting insulin independence in this population of patients. CONCLUSION: Islet autotransplant recipients of a marginal islet doses were more likely to achieve insulin independence when transplanted with a greater number of smaller islets.
Authors: Klearchos K Papas; Clark K Colton; Andi Qipo; Haiyan Wu; Rebecca A Nelson; Bernhard J Hering; Gordon C Weir; Maria Koulmanda Journal: J Invest Surg Date: 2010-02 Impact factor: 2.533
Authors: Melena D Bellin; David E R Sutherland; Gregory J Beilman; Irene Hong-McAtee; A N Balamurugan; Bernhard J Hering; Antoinette Moran Journal: Transplantation Date: 2011-02-15 Impact factor: 4.939
Authors: Takayuki Anazawa; Shuichiro Matsumoto; Yukihide Yonekawa; Gopalakrishnan Loganathan; Joshua J Wilhelm; Sajjad M Soltani; Klearchos K Papas; David E R Sutherland; Bernhard J Hering; A N Balamurugan Journal: Transplantation Date: 2011-03-15 Impact factor: 4.939
Authors: A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245
Authors: E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro Journal: Diabetes Date: 2001-04 Impact factor: 9.461
Authors: David E R Sutherland; Angelika C Gruessner; Annelisa M Carlson; Juan J Blondet; A N Balamurugan; Katie F Reigstad; Gregory J Beilman; Melena D Bellin; Bernhard J Hering Journal: Transplantation Date: 2008-12-27 Impact factor: 4.939
Authors: James F Markmann; Shaoping Deng; Xiaolun Huang; Niraj M Desai; Ergun H Velidedeoglu; Chengyang Lui; Adam Frank; Eileen Markmann; Maral Palanjian; Kenneth Brayman; Bryan Wolf; Ewan Bell; Marko Vitamaniuk; Nicolai Doliba; Franz Matschinsky; Clyde F Barker; Ali Naji Journal: Ann Surg Date: 2003-06 Impact factor: 12.969
Authors: Varvara A Kirchner; Ty B Dunn; Gregory J Beilman; Srinath Chinnakotla; Timothy L Pruett; Joshua J Wilhelm; Sarah J Schwarzenberg; Martin L Freeman; Melena D Bellin Journal: Curr Treat Options Gastroenterol Date: 2017-12
Authors: Klearchos K Papas; Melena D Bellin; David E R Sutherland; Thomas M Suszynski; Jennifer P Kitzmann; Efstathios S Avgoustiniatos; Angelika C Gruessner; Kathryn R Mueller; Gregory J Beilman; Appakalai N Balamurugan; Gopalakrishnan Loganathan; Clark K Colton; Maria Koulmanda; Gordon C Weir; Josh J Wilhelm; Dajun Qian; Joyce C Niland; Bernhard J Hering Journal: PLoS One Date: 2015-08-10 Impact factor: 3.240
Authors: Geun Soo Kim; Jong Hyun Lee; Du Yeon Shin; Han Sin Lee; Hyojun Park; Kyo Won Lee; Heung-Mo Yang; Sung Joo Kim; Jae Berm Park Journal: Sci Rep Date: 2020-01-21 Impact factor: 4.379